Why does the same biomaterial need different biocompatibility testing for different devices?

ISO 10993 biological evaluation requirements are determined not just by what a material is, but by how and how long it contacts the body — its "nature and duration of body contact" — because a material perfectly acceptable for brief surface skin contact can pose an unacceptable risk with prolonged implantation, and vice versa in some cases. A silicone that has passed testing as a short-term surface-contact material (like a temporary skin adhesive component) still requires additional, more extensive testing — including chronic toxicity, genotoxicity, and implantation studies — before it can be used in a permanent implant, because the biological evaluation endpoints required scale directly with contact duration (limited, prolonged, or permanent) and contact category (surface, external communicating, or implant device).

What is the difference between biocompatibility and biostability?

Biocompatibility describes whether a material provokes an unacceptable biological response — toxicity, inflammation, immune reaction, or carcinogenicity — from the body it contacts. Biostability describes whether the material itself resists degradation, corrosion, or breakdown over its intended service life inside the body's chemically aggressive, enzyme-rich, saline environment. The two properties are related but distinct and can vary independently: a material can be highly biocompatible (provoking no adverse reaction) while still being biodegradable by design (intentionally not biostable, as with a resorbable suture), or conversely, a material could in principle be extremely biostable while still being poorly biocompatible if it provokes chronic inflammation despite structurally persisting unchanged.

Why is titanium the dominant material for load-bearing orthopedic and dental implants?

Titanium and its alloys (most commonly Ti-6Al-4V) combine several properties that are difficult to find together in a single material class: excellent biocompatibility due to a stable, self-healing native oxide layer (titanium dioxide) that forms spontaneously on exposure to air or bodily fluids and resists further corrosion; a favorable strength-to-weight ratio and fatigue resistance suited to cyclic mechanical loading over years of use; and a demonstrated long clinical track record establishing both safety and manufacturing/machining processes. Titanium is not perfect — its elastic modulus (roughly 110 GPa) is still substantially higher than cortical bone (roughly 15-20 GPa), which can cause stress shielding around an implant over time — but the combination of corrosion resistance, mechanical performance, and clinical history has made it the default choice for hip and knee implants, dental implants, and spinal hardware despite ongoing materials research into lower-modulus alternatives.

Engineering·10 min read·August 7, 2026

🧬 Biomaterials Selection and Biocompatibility: The ISO 10993 Framework

A guide to biomaterials engineering and the ISO 10993 biocompatibility testing framework — material classes used in medical devices, the biological evaluation endpoints required by contact type and duration, and how material selection drives testing scope.

By EngineersUniverse Editorial Team

Engineering Editorial & Technical Review Team

Published August 7, 2026

Material Selection Is Never Purely a Mechanical Engineering Decision

Selecting a material for a medical device is never purely a question of mechanical properties, cost, or manufacturability the way it might be in a non-medical application — every candidate material has to simultaneously satisfy the device's functional and mechanical requirements and demonstrate an acceptable biological response from the tissue or fluid it will contact. This dual requirement is why biomaterials engineering exists as a distinct sub-discipline within biomedical engineering, sitting at the intersection of materials science and toxicology/immunology, and why device engineers cannot simply select the mechanically optimal material and treat biocompatibility as a testing formality performed afterward — material choice and biocompatibility strategy have to be considered together from the earliest design stage.

Major Biomaterial Classes Used in Medical Devices

Metals and Metal Alloys

Metals are the default choice wherever a device needs high strength, fatigue resistance, and load-bearing capability. Titanium and its alloys (particularly Ti-6Al-4V) dominate orthopedic and dental implants due to their spontaneously forming, self-healing titanium dioxide passive layer, which provides excellent corrosion resistance and biocompatibility. Cobalt-chromium alloys offer higher wear resistance and are common in articulating implant surfaces like hip and knee joint bearings. Stainless steel (typically 316L, a low-carbon, molybdenum-containing grade) remains widely used for temporary or lower-cost implants such as bone plates, screws, and some stents, though it is generally considered less biocompatible over the very long term than titanium or cobalt-chromium alternatives.

Polymers

Polymers offer design flexibility, a wide range of mechanical properties from rigid to highly elastic, and — critically — the option of engineered biodegradability. Ultra-high-molecular-weight polyethylene (UHMWPE) is the standard bearing surface material in hip and knee replacements due to its exceptionally low friction and wear resistance against a metal or ceramic counter-surface. PEEK (polyether ether ketone) has become a widely used spinal implant material because its elastic modulus is much closer to bone than titanium's, reducing stress-shielding risk, while also being radiolucent (allowing clear post-operative imaging without metal artifact). Silicone is used extensively for its biological inertness and flexibility in applications from catheters to breast implants. Bioresorbable polymers such as PLA (polylactic acid) and PGA (polyglycolic acid) are engineered to degrade in a controlled, predictable timeframe, used in resorbable sutures and increasingly in resorbable orthopedic fixation and drug-eluting stent scaffolds, eliminating the need for a second surgery to remove hardware.

Ceramics

Ceramics such as alumina and zirconia offer extremely high hardness, wear resistance, and — for zirconia-toughened alumina composites specifically — improved fracture toughness compared to earlier brittle ceramic formulations, making them attractive for hip joint bearing surfaces where wear-particle-induced inflammation is a long-term failure mode of concern with polymer bearings. Hydroxyapatite, a calcium phosphate ceramic chemically similar to the mineral component of natural bone, is used as a bioactive coating on implant surfaces to encourage direct bone bonding (osseointegration) rather than serving as a structural bearing material itself.

The ISO 10993 Biological Evaluation Framework

ISO 10993, "Biological evaluation of medical devices," is the internationally harmonized, multi-part standard series governing how a device's biocompatibility must be evaluated before it can be used on or in the human body. The framework's central organizing logic, laid out in ISO 10993-1, is that required biological testing scales with two variables: contact category (surface-contacting, external communicating, or implant devices) and contact duration (limited, ≤24 hours; prolonged, 24 hours to 30 days; or permanent, greater than 30 days).

Core Biological Evaluation Endpoints

Cytotoxicity (ISO 10993-5) — whether the material or its extractable/leachable chemicals kill or damage cells in an in vitro cell culture test; required for essentially every device category and duration as a baseline screen.
Sensitization (ISO 10993-10/23) — whether the material can provoke an allergic (delayed hypersensitivity) immune response after repeated exposure.
Irritation (ISO 10993-10/23) — whether the material causes local inflammation at the site of skin, mucosal, or tissue contact.
Systemic toxicity, acute and subchronic (ISO 10993-11) — whether leachable substances cause toxic effects beyond the local contact site, tested at increasing exposure durations for longer-contact devices.
Genotoxicity (ISO 10993-3) — whether the material or its extractables can damage DNA, required for any device with prolonged or permanent contact.
Implantation effects (ISO 10993-6) — direct histological evaluation of the local tissue response to an implanted material over time, required for implant-category devices.
Hemocompatibility (ISO 10993-4) — required for any device contacting blood, evaluating thrombosis, coagulation, platelet activation, hemolysis, and complement/immune activation risk.

A permanently implanted, blood-contacting device (such as a mechanical heart valve) sits at the far end of nearly every axis of this framework simultaneously, requiring the full suite of endpoints including chronic implantation studies and comprehensive hemocompatibility evaluation — while a short-term, surface-contacting device (such as an external wound dressing) may only require cytotoxicity, sensitization, and irritation testing. Determining exactly which endpoints apply to a specific device, material, and contact profile — via the ISO 10993-1 biological evaluation flowchart — is one of the earliest and most consequential steps in a device's biocompatibility strategy, because it directly sets the testing scope, timeline, and cost that will gate regulatory submission.

Chemical Characterization as a Modern Complement to Biological Testing

Increasingly, regulators and ISO 10993-18 favor a chemical characterization-first approach — analytically identifying and quantifying every extractable and leachable chemical from a material — as a way to reduce reliance on animal testing where a material's chemical profile can already be shown, through toxicological risk assessment, to fall within established safe exposure limits. This shift reflects both an ethical push to reduce animal testing and a scientific recognition that chemical characterization can, in many cases, provide a more precise and reproducible basis for biological safety assessment than traditional bulk biological assays alone.

Topics covered

biomaterials engineeringISO 10993biocompatibility testingmedical device material selectioncytotoxicity testingsensitization irritation testingimplant materialstitanium alloy implantsPEEK biomaterialbiocompatible polymers